ESMO Patient Coalition Forum Prostate Cancer: Bridging the GAP in Europe Europa Uomo: Coalition of independent patient led prostate cancer groups. Louis.

Slides:



Advertisements
Similar presentations
European Partnership for Action Against Cancer Speaker: Marija Seljak High Level Conference on EU Health Programmes, Results and Future Perspectives Brussels,
Advertisements

Engaging Patients and Other Stakeholders in Clinical Research
European Innovation for Active and Healthy Ageing
Improving outcomes for older people: Monitoring and regulating standards Ann Close 8 th June 2011.
National Prostate Cancer Audit Heather Payne, NPCA Oncological Clinical Lead Consultant Clinical Oncologist, UCL.
A rights-based approach for older people in long-term care The European WeDO experience by Maude Luherne, Policy and projects officer 3 April 2014, UN.
Barriers to Men’s Healthcare Patient Imperatives in the face of professional controversy Virgil Simons Founder & President The Prostate Net, Inc.®
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
The European Kidney Health Alliance Working together to reduce the incidence and impact of kidney disease in Europe.
The purpose of this Unit is to enable individuals to develop the key principles, values and attitude which are central to high quality care practice Key.
AVOID A CHRONIC PAIN AS A PATIENTS’ RIGHT Teresa Petrangolini Active Citizenship Network - PAE.
The burden of RMDs on patients and their families The value of early intervention, prevention and better management of RMDs Marios Kouloumas Chairperson.
Otis W. Brawley, M.D. Chief Medical and Scientific Officer Executive Vice President American Cancer Society Professor of Hematology, Medical Oncology,
Rare Diseases Working Group Luzern, 24 September 2010.
Introducing NICE... Gateshead Council Gillian Mathews Implementation consultant - north.
M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
ADAMOS ADAMOU, MEDICAL ONCOLOGIST MEMBER OF THE EUROPEAN PARLIAMENT.
Prostate Screening in 2009: New Findings and New Questions Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancer.
Health Care Reform Through the Cancer Lens State and Private Sector Reforms for Hispanic Healthcare Edward E. Partridge, MD National Board President American.
Cancer Survival Toolbox Lynn Barwick, LCSW Oncology Social Worker ¡Vida! Educational Series - Promoting Good Health.
PATIENT AND CITIZEN RIGHTS:A STATEMENT OF VALUES E.U. OPEN FORUM S.KYRIAKIDES President EUROPA DONNA.
A National Approach to Cancer Control in Canada Remarks by Jeff Lozon, Chair Canadian Partnership Against Cancer.
Standards for the Pharmaceutical Oncology Service in Europe through the eyes of patients What a patient expects from his pharmacist Louis Denis Secretary.
A/Prof Brian Cox Cancer Epidemiologist Dunedin. Research Associate Professor Brian Cox Hugh Adam Cancer Epidemiology Unit Department of Preventive and.
European Society of Cardiology Cardiovascular diseases in women.
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
1 "Cancer and the European Citizen – it’s time to deliver! Francesco De Lorenzo ECPC President ECPC Members in Action Conference 2009 ALL CANCER PATIENTS.
Patients Rights & Advocacy Discrimination Elisabetta Iannelli ECPC Secretary Warsaw, November 27th 2005.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
A GENERAL OVERVIEW OF PROSTATE CANCER. PROSTATE CANCER 101 SPONSORED BY THE CALIFORNIA STATE PROSTATE CANCER COALITION AND THE NATIONAL ALLIANCE OF STATE.
American Cancer Society Prostate Cancer Activities 2007 African American Prostate Cancer Disparity Summit September 28, 2007 Washington, D.C.
“The African American Prostate Cancer Crisis in Numbers”
E-health conference, Brussels, May 2003 European Public Health Alliance n A network of 90 non governmental and not-for-profit organisations across Europe.
Overdetection of prostate cancer ESMO Brussel 2007 Chris H.Bangma Erasmus University Medical Centre Rotterdam, The Netherlands.
Prostate Cancer Screening in African American Men Mark H. Kawachi, MD FACS Director, Prostate Cancer Center City of Hope, National Medical Ctr.
S Collins, I-Base: HIV and cancerUK-CAB April 2013 Introduction to HIV and cancer Simon Collins HIV i-Base.
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
Management of Senior Adults with Prostate Cancer Patients’ Perspectives Louis Denis - Europa Uomo Milan,
Massachusetts Medical Society Robyn Alie Manager, Public Health and Education Frank Fortin Chief Digital Strategist and Director of Communications.
Accelerating Evidence-based Action in Cancer Control and Facilitating Virtual Collaboration in Canada through Cancerview.ca International Cancer Control.
The PSA Conundrum: Test or Die Patient Imperatives in the face of professional controversy Virgil Simons Founder & President The Prostate Net, Inc.®
Intra-trust lymphoedema awareness training programme Gillian McCollum Lymphoedema Clinical Lead.
A Clinical Profile of Male Health in the Bahamas “Real Men Die from Prostate Cancer” A Clinical Profile of Male Health in the Bahamas “Real Men Die from.
The Informed Patient An EU Framework for Action European Health Forum Gastein Peter Singleton Senior Associate, Cambridge University Health.
Prostate Cancer Screening Risk Management Ben Inch.
1 Ambassador Program Presentation Prevention & Early Detection PROSTATE CANCER.
PROCABIO A European initiative to develop tailored treatment of prostate cancer by biomarkers.
EARIP Stakeholder Workshop Models and healthcare systems: transferability of best practice across Europe Dr. Aurélien PEREZ European Commission Health.
Europa Uomo The European Prostate Cancer Coalition Jean Moreau & Louis Denis OECI Workshop, Avignon,
1 The Informed Patient The Doctor Knows Best, Does He? Gastein, October 6, 2005.
A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE.
EUROPA UOMO The European Prostate Cancer Patients Coalition L. Denis Monaco, October 6,2006.
Blueshieldcafoundation.org Pathways to Health and Safety: Bridging the divide between healthcare and domestic violence Presenter: Lucia Corral Peña, Blue.
Rationalizing the New Healthcare Paradigm Scientific Agenda vs. Patient Imperatives Scientific Agenda vs. Patient Imperatives.
Why europa uomo and eso can cooperate? Alberto Costa ESO Director.
EUROPEAN HEALTH FORUM – BAD GASTEIN PARALLEL FORUM A 1 “HEALTH CHALLENGES IN THE ENLARGED EUROPE” “THE ROLE OF PATIENTS IN PUBLIC HEALTH AND HEALTH SERVICES”
Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,
1 ECPC PAPER ON BLADDER CANCER FRANCESCO DE LORENZO Brussels, 20 April 2016.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
CHAPS - The Men’s Health Charity PROSTATE CANCER To Screen or Not To Screen - That is the Only Question Chris Booth MBBS, FRCS Emeritus.
WHO WE ARE PEMBE HANIM IS A TURKISH UMBRELLA CANCER PATIENTS ORGANISATION FOUNDED IN 2010 BY NEVVAL SEVINDI BC SURVIVOR TWICE ,ANTHROPOLOGIST WRITER,
WHO WE ARE PEMBE HANIM IS A TURKISH UMBRELLA CANCER PATIENTS ORGANISATION FOUNDED IN 2010 BY NEVVAL SEVINDI TWICE BC SURVIVOR TWICE,ANTHROPOLOGIST WRITER,
Musculoskeletal Health in Europe
Informational Needs During Active Surveillance for Prostate Cancer:
Migraine - an overlooked neurological disorder
Working Package 7 (WP7) Health Care
Presentation transcript:

ESMO Patient Coalition Forum Prostate Cancer: Bridging the GAP in Europe Europa Uomo: Coalition of independent patient led prostate cancer groups. Louis Denis Brussels,

Prostate Cancer: The common problem Our diversity in identity and culture which we like to keep in the face of: rising incidence (age) outcome variations across Europe optimal prevention and treatment holistic patient-centered care requires collaboration with all stakeholders in a social health care system. Europa Uomo, 2007

The Rudy Giulani Statement Radio ad against universal health care. “My chances of surviving prostate cancer in the USA is 82% vs. 44% in the UK under socialized medicine” A scare tale that is false (the UK survival is 74.4%) a statistical illusion to be deleted with the five year survival concept. P. Krugman, IHTA, 2007

Prostate Cancer: Specific problems Increasing burden to civil society and patients numbers. Uncertainty in optimal medical prevention and treatment. Outcome variations in Europe today. Advocacy in holistic patient-centered care. Europa Uomo, 2007

Incidence PCA & Bra in Europe Men PCaWomen Bra Inc.MortalityInc.Mortality ,168,2275,188, ,567,8319,9 85,3 Europa 25 * thousands, IARC

Background of this Tsunami 1.Microscopic cancer can be found from age 30 and is present in 50% of all men at age These cancers are indolent (sleeping) but grow slowly. Detection is possible from volume 0.2 to 0.5 cc (28 to 29 doublings) over 20 years. We can detect up to 30% of cancer. 3.However the PCa incidence is only 10% with a mortality of 3% after 15 years. OCA, 2007

Conclusions on Incidence 1.Prostate cancer is a chronic disease in senior adults (peak inc, mort > 70 y.). 2.In PSA-screened cancers we find 53% of these small cancers (ERSPC). 3.Overdetection is a fact but overtreatment a mistake (PRIAS). OCA, 2007

Uncertainty in Prevention/Treatment 1.Total PSA aspecific & variable 2.Biopsies and pathology difficult. 3.Choice primary treatment (Active Surveillance) 4.Hormonal treatment (Watchful Waiting) OCA, 2007

The Physician before Uncertainty Cause:Limitations in medical and/or personal knowledge Reaction:Retracts in personal discipline/ show of self-assurance Solution:Reflect – Respect Others – Communication J. Groopman, How Doctors Think, 2007

The lost patient Tsunami information (Professionals, media, friends ) The medical labyrinth EBM Guidelines Nomograms Loss of personality Outcome results Statistics PANIC OCA, 2007

The Europa Uomo Strategy 1 Partnership with professional organisations: 1.Request for update on all aspects of prostate cancer European Association of Urology (EAU) European Society of Medical Oncology (ESMO) European Cancer Organisation (ECCO) 2.Support multiprofessional treatment 3.Open communication & collaboration Europa Uomo, 2007

Example EAU – EU Collaboration Key topics Prostate Awareness day BPH symptoms not related to cancer. 2.Early detection with PSA but rather PSA kinetics as tools to identify risk. 3.These cancers do not always need treatment (Active Surveillance) 4.Hormonal therapy impacts quality of life but side-effects can be reduced. EAU, 2007

Aims Europa Uomo on optimal Prevention/Treatment 1.Develop individualized treatment based on state of the art principles and personalized patient care. 2.Help reduce overtreatment of prostate cancer. Europa Uomo, 2007

Outcome variations in Europe today Need for appropriate, validated and understandable information/communication Appropriate = useful Validated = objective Understandable = direct Europa Uomo, 2007

GAP TRUTH versus REALITY OCA, 2007 ‘The growing gap’ Real care Knowledge Rich Transparency Decision-sharing Treatment Poor Olympic Proposals Neglect Prevention

Europa Uomo Strategy 2 Collaboration with European School of Oncology (ESO) on: Information Communication Education Website Cancerworld.org online

Advocacy in holistic Patient Care Europa Uomo Strategy 3 1.Personal physician “trust” Privacy, Confidentiality, Dignity Onco-psychology, social support 2.Collaboration Europa Donna We go for an unisono advocacy under the European Cancer Patient Coalition (ECPC). Europa Uomo, 2007

Europa Uomo Glosing the Gap Strategy 1.Partnership with professional organisations (EAU, ESMO, ECCO). 2.Collaboration on information, communication, education (ESO & Cancerworld). 3.Unisono advocacy (ECPC, Europa Donna). Thank you for caring